Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Analyzing the Health Effects of Space Travel with AI

Space is a frontier for global innovation, but space doesn’t come without its limits. As exploration grows, the importance of human health in outer space grows as well. Shashi Jain, Senior Strategic Innovation Manager at Intel, and Dr. John Kalantari, Chief Technology Officer at Yrikka, Inc. spoke  with host Tyler Kern about the movement collaboration…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from Intel on MarketScale.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

Space is a frontier for global innovation, but space doesn’t come without its limits. As exploration grows, the importance of human health in outer space grows as well. Shashi Jain, Senior Strategic Innovation Manager at Intel, and Dr. John Kalantari, Chief Technology Officer at Yrikka, Inc. spoke with host Tyler Kern about the movement collaboration between Intel and the Frontier Development Lab an applied artificial intelligence research accelerator established to maximize new AI technologies and capacities emerging in academia and space and exploration.

The Intel and Frontier Development Lab collaboration aims to improve the data collection of astronauts. The collaboration is working to make space exploration safer and healthier through artificial intelligence. “The collaboration with Intel rose organically. We were already applying AI and machine learning in the space, specifically for decision making,” says Dr. Kalantari.

“AI, when it comes to terrestrial medicine, is suffering from the same challenges as astronaut health and space medicine,” says Dr. Kalantari, who believes part of the issue is combining the health data of astronauts safely and securely into one database. “To train an AI, you have to bring together all the data into one spot and use that to train the algorithms,” says Shashi Jain.

The risk of spending time in space is detrimental to the human body. According to NASA, when astronauts are in microgravity, the human body loses muscle mass and bone density. Physically and psychologically, the impact on human bodies could be detrimental. The mission could fail if health issues hinder a crew member on a mission.

Currently, the effects on astronauts are similar to how we gather health information on earth. Data is collected through observation and measuring vitals. “We use this collection of data before, during, and after each mission to identify any prominent biomarkers that could be indicators of disease progression,” says Jain. The main challenge of the project is maintaining the privacy of the individuals so that the collected data can train AI for the future.

For more information on the power of technology and the future of astronaut health, connect with Shashi Jain and Dr. John Kalantari on LinkedIn or explore Intel’s Health and Life Sciences page.

Subscribe to this channel on Apple Podcasts, Spotify, and Google Podcasts to hear more from the Intel Network & Edge Solutions Group.

Intel

Part of this channel

Intel

Silicon and AI platforms powering enterprise and edge compute.

Visit the channel

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Medicare sets $137.53 maximum add-on payment per eligible inpatient case for CT triage AI

Medicare sets $137.53 maximum add-on payment per eligible inpatient case for CT triage AI

Medicare has announced a maximum add-on payment of $137.53 per eligible inpatient case for the use of AI in CT triage, utilizing Aidoc’s CT Body triage technology. This move emphasizes the importance of workflow integration, governance, and coding in hospitals employing radiology AI. The new technology add-on payment (NTAP) signifies a clear investment in AI-driven healthcare solutions.

  • 01Medicare introduces a $137.53 per-case payment for AI in CT triage.
  • 02Hospitals must integrate AI with proper workflow, governance, and coding.
  • 03The NTAP reflects investment in radiology AI solutions.

Aug 30, 2026

Rasonque’s 13.2-month survival result is about to hit hospital formularies

Rasonque’s 13.2-month survival result is about to hit hospital formularies

FDA has cleared Revolution Medicines' drug Rasonque for treating metastatic pancreatic adenocarcinoma. Hospitals are now integrating this drug into their formularies, focusing on operations like pathways, genotyping, and specialty pharmacy flow.

  • 01Rasonque has received FDA clearance for treating metastatic pancreatic adenocarcinoma.
  • 02Hospitals are working on integrating Rasonque into their formularies.
  • 03Operational focus includes pathways, genotyping, and specialty pharmacy flow.

Aug 30, 2026

Real-time radiation dose tracking is moving from badges to live dashboards in procedure rooms

Real-time radiation dose tracking is moving from badges to live dashboards in procedure rooms

Radiation Detection Company has introduced a live radiation dose tracking system called Radiant that updates every 0.2 seconds. GE HealthCare has developed browser-based imaging access for hospitals, transforming how radiation monitoring is managed in procedure rooms. This advancement in live dashboards is enhancing real-time monitoring capabilities in healthcare facilities.

  • 01Radiation Detection Company's Radiant updates radiation dose data every 0.2 seconds.
  • 02GE HealthCare has developed browser-based imaging access for better hospital management.
  • 03Live dashboards are transforming radiation monitoring in procedure rooms.

Aug 30, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512